Inhibitors | Comment | Organism | Structure |
---|---|---|---|
2-[[5-cyano-4-(3-methoxyphenyl)-6-oxo-1,6-dihydropyrimidin-2-yl]sulfanyl]-N-[5-(propan-2-yl)thiophen-2-yl]butanamide | 0.01 mM, 24.4% inhibition | Homo sapiens | |
5-[(2E)-2-[(4-bromophenyl)methylidene]hydrazinyl]-1-(naphthalen-1-yl)tetrazolidine | 0.01 mM, 54.3% inhibition | Homo sapiens | |
7-amino-2-[(2E)-3-(2H-1,3-benzodioxol-5-yl)prop-2-enoyl]-4-bromocyclohepta-2,4,6-trien-1-one | 0.01 mM, 21.4% inhibition | Homo sapiens | |
additional information | a high throughput virtual screening cascade protocol is validated and can be employed in discovery of IDO1 inhibitors | Homo sapiens | |
N-[(1,3-benzothiazol-2-yl)sulfanyl]-2-nitrobenzene-1-sulfonamide | 0.01 mM, 35.9% inhibition | Homo sapiens | |
[3-(4-bromobenzoyl)-1,2-oxazol-4-yl](naphthalen-2-yl)methanone | 0.01 mM, 28.4% inhibition | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-tryptophan + O2 | Homo sapiens | - |
N-formyl-L-kynurenine | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P14902 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
L-tryptophan + O2 | - |
Homo sapiens | N-formyl-L-kynurenine | - |
? |
Synonyms | Comment | Organism |
---|---|---|
IDO1 | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0088 | - |
pH 6.5, 37°C | Homo sapiens | 5-[(2E)-2-[(4-bromophenyl)methylidene]hydrazinyl]-1-(naphthalen-1-yl)tetrazolidine | |
0.0238 | - |
pH 6.5, 37°C | Homo sapiens | N-[(1,3-benzothiazol-2-yl)sulfanyl]-2-nitrobenzene-1-sulfonamide |
General Information | Comment | Organism |
---|---|---|
drug target | the enzyme is a promising target for cancer immunotherapy | Homo sapiens |
physiological function | the enzyme plays an important role in the immune escape of tumors | Homo sapiens |